| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2100655 | Best Practice & Research Clinical Haematology | 2015 | 7 Pages |
Abstract
While allogeneic hematopoietic stem cell transplantations have a curative potential, infections and graft-versus-host disease remain significant problems. The intestinal microbiota can influence responses to cancer chemotherapy and the role of the microbiota in affecting allogeneic hematopoietic stem cell transplantation outcomes is increasingly appreciated. The following paper discusses the most recent developments in this area.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ying Taur, Robert R. Jenq, Carles Ubeda, Marcel van den Brink, Eric G. Pamer,